Inactivating genetic and epigenetic changes in GNAS, leading to Gsα deficiency, are known to be associated with several disorders, including different variants of pseudohypoparathyroidism, which may feature severe, early-onset obesity as part of their clinical manifestations. The gene discussed is GNAS; the disease is pseudohypoparathyroidism type 1A.